ProCE Banner Activity

Optimal Management of Immune-Related Adverse Events for Patients With Advanced RCC

Slideset Download
Download these slides from a live webinar for the most recent data on the optimal management of treatment-related adverse events for patients with RCC.

Released: June 05, 2022

Expiration: June 04, 2023

No longer available for credit.

Share

Faculty

Eric Jonasch

Eric Jonasch, MD

Assistant Professor, Genitourinary Medical Oncology
The University of Texas M.D. Anderson Cancer Center
Houston, Texas

Provided by

Provided by National Comprehensive Cancer Network.
ProCE Banner

Supporters

Supported by educational grants from

AVEO Pharmaceuticals, Inc.

Eisai Inc.

Exelixis

Merck Sharp & Dohme Corp.

Pfizer, Inc.

Faculty Disclosure

Primary Author

Eric Jonasch, MD

Assistant Professor, Genitourinary Medical Oncology
The University of Texas M.D. Anderson Cancer Center
Houston, Texas

Eric Jonasch, MD, has disclosed that he has received funds for research support from Arrowhead, Merck, NiKang, and Novartis and consulting fees from Aveo, Aravive, Eisai, Exelixis, Merck, NiKang, Novartis, and Takeda.